Timothy Moore
Chief Tech/Sci/R&D Officer presso ALLOGENE THERAPEUTICS, INC.
Patrimonio netto: 2 M $ in data 29/02/2024
Profilo
Presently, Timothy L.
Moore occupies the position of Chief Technical Officer & Executive Vice President at Allogene Therapeutics, Inc. Mr. Moore is also on the board of BioLife Solutions, Inc. and Cerus Corp.
and Member of International Society for Pharmaceutical Engineering and Member of Parenteral Drug Association.
In his past career Mr. Moore was President & Chief Technical Officer at PACT Pharma, Inc., Chief Operating Officer for Instil Bio, Inc., Vice President-Operations for CSL Behring LLC, Executive Vice President-Technical Operations at Kite Pharma, Inc., SVP & Head-Pharmaceutical Technical Operations at Genentech, Inc. and Vice President-Operations of Aventis Behring.
Timothy L.
Moore received an undergraduate degree from The University of Tulsa and a graduate degree from Northwestern University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
25/01/2024 | 282 819 ( 0.17% ) | 1 M $ | 29/02/2024 | |
BIOLIFE SOLUTIONS, INC.
0.07% | 08/03/2024 | 29 897 ( 0.07% ) | 505 259 $ | 29/02/2024 |
CERUS CORPORATION
0.06% | 07/06/2023 | 105 073 ( 0.06% ) | 229 059 $ | 29/02/2024 |
Posizioni attive di Timothy Moore
Società | Posizione | Inizio |
---|---|---|
CERUS CORPORATION | Director/Board Member | 05/09/2018 |
BIOLIFE SOLUTIONS, INC. | Director/Board Member | 01/09/2022 |
ALLOGENE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/04/2023 |
International Society for Pharmaceutical Engineering
International Society for Pharmaceutical Engineering Miscellaneous Commercial ServicesCommercial Services The International Society for Pharmaceutical Engineering is a nonprofit association that focuses on scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle. The non-profit company is based in Tampa, FL. The company engages with all levels of regulators to ensure that their education, training, document development, and interpretation are cutting-edge and focused on enabling the production and supply of therapies and devices with unmatched levels of flow, efficiency, and quality sustainably and at scale. John Bournas has been the CEO of the company since 2015. | Corporate Officer/Principal | - |
Parenteral Drug Association | Corporate Officer/Principal | - |
Precedenti posizioni note di Timothy Moore
Società | Posizione | Fine |
---|---|---|
INSTIL BIO, INC. | Chief Operating Officer | 08/12/2022 |
KITE PHARMA INC | Chief Tech/Sci/R&D Officer | - |
Aventis Behring | Corporate Officer/Principal | 01/07/2004 |
Cognate BioServices, Inc.
Cognate BioServices, Inc. BiotechnologyHealth Technology Cognate BioServices, Inc. engages in the provision of commercialization services to regenerative medicine, cellular immunotherapy, and cell therapy companies. It offers cGMP clinical and commercial manufacturing; process and assay development and optimization; logistics, supply chain, and manufacturing support services; and clinical, regulatory, and custom services. The company was founded in 2002 and is headquartered in Memphis, TN. | Director/Board Member | - |
░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░ | - |
Formazione di Timothy Moore
Northwestern University | Graduate Degree |
The University of Tulsa | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 4 |
---|---|
BIOLIFE SOLUTIONS, INC. | Health Technology |
CERUS CORPORATION | Health Technology |
ALLOGENE THERAPEUTICS, INC. | Health Technology |
INSTIL BIO, INC. | Health Technology |
Aziende private | 9 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Aventis Behring | Health Technology |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Health Technology |
Cognate BioServices, Inc.
Cognate BioServices, Inc. BiotechnologyHealth Technology Cognate BioServices, Inc. engages in the provision of commercialization services to regenerative medicine, cellular immunotherapy, and cell therapy companies. It offers cGMP clinical and commercial manufacturing; process and assay development and optimization; logistics, supply chain, and manufacturing support services; and clinical, regulatory, and custom services. The company was founded in 2002 and is headquartered in Memphis, TN. | Health Technology |
International Society for Pharmaceutical Engineering
International Society for Pharmaceutical Engineering Miscellaneous Commercial ServicesCommercial Services The International Society for Pharmaceutical Engineering is a nonprofit association that focuses on scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle. The non-profit company is based in Tampa, FL. The company engages with all levels of regulators to ensure that their education, training, document development, and interpretation are cutting-edge and focused on enabling the production and supply of therapies and devices with unmatched levels of flow, efficiency, and quality sustainably and at scale. John Bournas has been the CEO of the company since 2015. | Commercial Services |
Parenteral Drug Association | |
Kite Pharma, Inc.
Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
PACT Pharma, Inc.
PACT Pharma, Inc. Pharmaceuticals: MajorHealth Technology PACT Pharma, Inc. develops pharmaceutical products. It offers personalizes adoptive cell therapies with neoantigen-targeted T cells against cancer. The company is headquartered in South San Francisco, CA. | Health Technology |
Fusionkite |